Jan Kaminski

Executive Chairman

Jan brings decades of global growth and leadership experience to the CryoStasis team, including 15 years as President of Colonnade Investments. He’s guided venture-backed start-ups to successful M&As and held several advisory and board positions among a number of corporations and not-for-profits. His experience spans industries including agriculture, enterprise management, medical device technologies and more.

Keith Millar

Chief Executive Officer

Keith has focused his career on disruptive products. Keith has been leading teams in various markets and industries for the last 25 years. Keith’s engineering background, MBA and leadership experience yields a powerful mix of business and technology skills. Keith has led teams in Aerospace, Healthcare, IT software & services. Keith has a proven record of successfully aligning company core competencies with customer problems.

Thomas Allen

Chief Science Officer

Tom is a physical chemist with an extensive academic and professional background. While doing a postdoctoral fellowship at Ohio State, Tom met his wife, Dr. Olga Kukal. Over the course of three decades, the two founded three biotechnical companies to actualize the transformative potential of Olga’s research. As CSO, Tom honours Olga’s memory by continuing to advance the research she began more than 40 years ago and that, together, they distilled into a life-changing technology.

Photis Loizides

Chief Medical Officer

Dr. Photis Loizides is a Plastic and Reconstructive Surgeon at Richmond Hospital and is the founder and operator of a successful Vancouver-based plastic surgery clinic. He is a Clinical Instructor of Surgery at the University of British Columbia. Fully accredited by the Royal College of Physicians and Surgeons, Photis has over a decade of experience performing reconstructive and cosmetic surgical procedures with extensive training in minimizing the effects of ischemic damage on tissues and organs.

Ross Morgan

Chief Financial Officer

Ross has more than 30 years’ senior financing, M&A, board of directors and operational experience supporting numerous early-stage, private and public companies, with a focus on high-tech. He is the current Managing Director of CFO4Results Inc., a consulting firm he acquired in 2010 and through which he’s advised dozens of companies ranging from biomedical to consumer products, patent licensing and software.

Chantal Hemens

Vice President of Operations

Chantal has over thirty years of combined technical and management experience in the biotech and telecommunications industries. In the past 17 years, she led teams in both small (<50) and medium (>500) size medical device organizations with focus on manufacturing, quality, and regulatory compliance. Chantal provided strategic and tactical leadership for manufacturing medical devices to achieve business critical objectives while meeting global regulatory and quality requirements and exceeding customer expectations. Chantal’s science and operations background, coupled with her passion for leading people, a strong combination with proven results.

Sebastian Hadjiantoniou

Vice President of Research and Development

Sebastian is a cellular biologist turned entrepreneur. Having completed his masters in neuroscience from Kings College London and Phd in cell biology from the University of Ottawa, his expertise lies in cellular life. He co-founded Incuvers, a hardware biotechnology company whose mission was to connect every researcher around the world in real time. The company raised over $1.5M in pre-seed funding and commercialized their flagship product IRIS in under 30 months. Sebastian’s academic and fast paced startup background brings an interdisciplinary lens and first principles approach to bringing product to market.